Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG) (TREG)
Characterizing Biomarkers of Early Parkinson's Disease Progression
Sponsor: Oregon Health and Science University
Terminated
COVID-19 Research Restrictions
Other terminated trials from Oregon Health and Science University
- Maternal Psychological Distress · Phase NA · Mar 2021
- Dyskinesias · Phase PHASE1 · Feb 2021
- Ataxia · Sep 2020
- Bell Palsy · Phase NA · Aug 2020
- Contraception · Phase NA · Jun 2017
See all terminations from Oregon Health and Science University
Other Movement Disorders trials with similar outcome
Listed as NCT03716258, this observational or N/A phase trial focuses on Movement Disorders and Parkinson Disease and remains terminated or withdrawn. Sponsored by Oregon Health and Science University, it has been updated 11 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2022 — Jul 2024 [monthly]
Terminated
Status: Suspended → Terminated
-
Dec 2021 — May 2022 [monthly]
Suspended
-
Apr 2021 — Dec 2021 [monthly]
Suspended
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Suspended
-
Nov 2020 — Jan 2021 [monthly]
Suspended
-
Apr 2020 — Nov 2020 [monthly]
Suspended
Status: Recruiting → Suspended
-
Aug 2019 — Apr 2020 [monthly]
Recruiting
-
Jan 2019 — Aug 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Jan 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Oregon Health and Science University
- Portland VA Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .